Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring

Abstract

BackgroundAdverse effects in diabetic mothers offspring (DMO) are a major concern of increasing incidence. Among these, chronic central complications in DMO remain poorly understood, and in extreme cases, diabetes can essentially function as a gestational brain insult. Nevertheless, therapeutic alternatives for DMO are limited.MethodsTherefore, we have analyzed the central long-term complications in the offspring from CD1 diabetic mothers treated with streptozotozin, as well as the possible reversion of these alterations by insulin administration to neonates. Brain atrophy, neuronal morphology, tau phosphorylation, proliferation and neurogenesis were assessed in the short term (P7) and in the early adulthood (10 weeks) and cognitive function was also analyzed in the long-term.ResultsCentral complications in DMO were still detected in the adulthood, including cortical and hippocampal thinning due to synaptic loss and neuronal simplification, increased tau hyperphosphorylation, and diminished cell proliferation and neurogenesis. Additionally, maternal diabetes increased the long-term susceptibility to spontaneous central bleeding, inflammation and cognition impairment in the offspring. On the other hand, intracerebroventricular insulin administration to neonates significantly reduced observed alterations. Moreover, non-invasive intranasal insulin reversed central atrophy and tau hyperphosphorylation, and rescued central proliferation and neurogenesis. Vascular damage, inflammation and cognitive alterations were also comparable to their counterparts born to nondiabetic mice, supporting the utility of this pathway to access the central nervous system.ConclusionsOur data underlie the long-term effects of central complications in DMO. Moreover, observed improvement after insulin treatment opens the door to therapeutic alternatives for children who are exposed to poorly controlled gestational diabetes, and who may benefit from more individualized treatments.

Effects of classical PKC activation on hippocampal neurogenesis and cognitive performance: mechanism of action

“…The improvement of ER272 treated mice was similar to that found in healthy mice treated with insulin by intranasal administration [48]. This suggests that the effect of ER272 on memory tasks may be as potent as other neurogenic drugs such as insulin [48,49]. However, we have not been able to directly demonstrate that the induction of neurogenesis is responsible for the improvement in memory and learning tasks.…”

Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage

“…Spine density was calculated (spines/10 μm) ( Infante-Garcia et al, 2015 ). Ratios of curvature were calculated by dividing the end-to-end distance of a dendrite segment by the total length between the two segment ends using Image J software ( Ramos-Rodriguez et al, 2017 ).…”

“…Sections were dehydrated in 70% ethanol for 15 min. They were stained with cresyl violet (Sigma, St. Louis, MO, United States) solution (0.5% w/v) for 10 min, as previously described (Ramos-Rodriguez et al, 2017). Sections were then fixed sequentially in 0.25% acetic acid, 100% ethanol and xylene for 2 min.…”

Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance

“…Likewise, STZ-induced T1D rats present a significant reduction in hippocampus Ab levels when treated with intranasal insulin (180). Interestingly, it has been shown that long-term complications observed on brain of offspring from STZ-induced diabetic mothers could be completely reversed through the intranasal administration of insulin (153). Regarding AD, in vivo studies showed that intranasal insulin administration was able to restore proper brain insulin signaling, increase synaptic proteins, and reduce Ab level and microglia activation (45) and protected against neurodegeneration and recovered memory deficits (84).…”